Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models00:57

Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models

472
Physiological pharmacokinetic models, often called flow-limited or perfusion models, typically assume a swift drug distribution between tissue and venous blood, creating a rapid drug equilibrium. This premise is based on the idea that drug diffusion is extremely fast, and the cell membrane presents no barrier to drug permeation. In this scenario, where no drug binding occurs, the drug concentration in the tissue equals that of the venous blood leaving the tissue. This greatly simplifies the...
472
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

342
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
342
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

320
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
320
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

467
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
467
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

2.8K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
2.8K
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

360
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
360

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A stochastic agent-based model for simulating tumor-immune dynamics and evaluating therapeutic strategies.

Mathematical biosciences and engineering : MBE·2026
Same author

Dynamics, Noise, Delays and the Gibbs and Conditional Entropy.

Entropy (Basel, Switzerland)·2026
Same author

Multiscale modeling reveals synergy between CCL19 and PD-1 blockade in reshaping the TNBC microenvironment.

NPJ systems biology and applications·2026
Same author

Modelling infectious disease transmission dynamics in conference environments: An agent-based approach.

Mathematical biosciences and engineering : MBE·2026
Same author

Effects of Multi-Phase Control Mechanism on Fibroblast Dynamics: A Segmented Mathematical Modeling Approach.

Bulletin of mathematical biology·2026
Same author

Combination therapy for colorectal cancer with anti-PD-L1 and cancer vaccine: A multiscale mathematical model of tumor-immune interactions.

Mathematical biosciences·2026

Related Experiment Video

Updated: Apr 19, 2026

Author Spotlight: Advancing Erythropoiesis Research - A Simplified Pipeline for Assessing Hematopoietic Stem Cell Function in Myelodysplastic Syndromes
08:53

Author Spotlight: Advancing Erythropoiesis Research - A Simplified Pipeline for Assessing Hematopoietic Stem Cell Function in Myelodysplastic Syndromes

Published on: January 10, 2025

1.2K

Understanding and treating cytopenia through mathematical modeling.

Jinzhi Lei1, Michael C Mackey

  • 1Zhou Pei-Yuan Center for Applied Mathematics, Tsinghua University, Beijing, 100084, China, jzlei@tsinghua.edu.cn.

Advances in Experimental Medicine and Biology
|December 7, 2014
PubMed
Summary

Mathematical modeling enhances understanding of blood disorders like neutropenia and thrombocytopenia. These tools also improve treatments for chemotherapy-induced cytopenia.

More Related Videos

Automated Quantification of Hematopoietic Cell – Stromal Cell Interactions in Histological Images of Undecalcified Bone
09:31

Automated Quantification of Hematopoietic Cell – Stromal Cell Interactions in Histological Images of Undecalcified Bone

Published on: April 8, 2015

12.1K
Modeling the Effects of Hemodynamic Stress on Circulating Tumor Cells using a Syringe and Needle
05:49

Modeling the Effects of Hemodynamic Stress on Circulating Tumor Cells using a Syringe and Needle

Published on: April 27, 2021

3.1K

Related Experiment Videos

Last Updated: Apr 19, 2026

Author Spotlight: Advancing Erythropoiesis Research - A Simplified Pipeline for Assessing Hematopoietic Stem Cell Function in Myelodysplastic Syndromes
08:53

Author Spotlight: Advancing Erythropoiesis Research - A Simplified Pipeline for Assessing Hematopoietic Stem Cell Function in Myelodysplastic Syndromes

Published on: January 10, 2025

1.2K
Automated Quantification of Hematopoietic Cell – Stromal Cell Interactions in Histological Images of Undecalcified Bone
09:31

Automated Quantification of Hematopoietic Cell – Stromal Cell Interactions in Histological Images of Undecalcified Bone

Published on: April 8, 2015

12.1K
Modeling the Effects of Hemodynamic Stress on Circulating Tumor Cells using a Syringe and Needle
05:49

Modeling the Effects of Hemodynamic Stress on Circulating Tumor Cells using a Syringe and Needle

Published on: April 27, 2021

3.1K

Area of Science:

  • Hematology
  • Mathematical Biology
  • Computational Medicine

Background:

  • Dynamic hematological diseases pose complex challenges in understanding their origins and developing effective treatments.
  • Existing therapeutic strategies require refinement to address specific cytopenias.

Purpose of the Study:

  • To review the application of mathematical modeling in hematological disease research.
  • To highlight advancements in understanding neutropenia and thrombocytopenia through dynamic models.
  • To explore model-driven strategies for managing chemotherapy-induced cytopenia.

Main Methods:

  • Review of existing literature on mathematical modeling of hematological diseases.
  • Analysis of how dynamic models contribute to understanding disease mechanisms.
  • Discussion of model-based therapeutic recommendations.

Main Results:

  • Mathematical modeling has significantly improved the comprehension of neutropenia and thrombocytopenia.
  • Dynamic models offer insights into the origins of these hematological conditions.
  • These models provide a basis for enhanced treatment strategies.

Conclusions:

  • Mathematical modeling is a powerful tool for advancing hematological disease research.
  • Model-informed approaches can lead to more effective treatments for cytopenias.
  • Further development and application of these models are crucial for clinical practice.